Professor Geoff Lindeman discusses genetics and breast cancer, as well as world first research in the BRCA-P clinical trial.
“Smarter screening” and a better understanding of the breast cancers women of color are more likely to develop are all crucial to helping these patients survive this disease at the same rates as their White counterparts.
Scientists at Case Western Reserve University have used artificial intelligence (AI) to identify new biomarkers for breast cancer that can predict whether the cancer will return after treatment—and which can be identified from routinely acquired tissue biopsy samples of early-stage breast cancer.
Most of us have heard about the BRCA1 and BRCA2 genes...but what about the PALB2 gene, which stands for Partner And Locator of BRCA2?
When you have cancer, getting the right treatment the first time is very important. A second opinion can help to ensure that you'll be getting the latest therapy with the best chance of effectively treating the type of cancer you have.
Every day, people are exposed to a variety of synthetic chemicals through the products they use or the food they eat. For many of these chemicals, the health effects are unknown.
Can immunotherapy treat breast cancer? For certain patients, the answer is yes.
New research has revealed that a one-year course of a drug called a PARP inhibitor can help to reduce the risk of breast cancer recurrence, and progression to secondary breast cancer, in people with early breast cancer with a change in the BRCA gene.
It’s estimated that between 5 to 10 percent of breast cancers result from inherited gene variations. Genetic testing can help detect gene variations that raise your risk of developing breast cancer.
After you get a breast cancer diagnosis, it likely won’t be long before your doctor starts talking to you about lymph nodes. Lymph node involvement is an important part of staging and treatment with breast cancer.